Connor, Clark & Lunn Investment Management »

Axsome Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $25M 209k 121.45
2025-06-30 $24M 225k 104.39
2025-03-31 $21M 176k 116.63
2024-12-31 $6.2M 74k 84.61
2023-12-31 $1.1M 14k 79.59
2022-03-31 $381k 9.2k 41.44